Sutura Therapeutics at BioTrinity 2024

Sutura Therapeutics is on the move! We're delighted to announce that our CEO, Edwin Wagena, will be attending the BioTrinity 2024 conference, the premier event for the life sciences industry, hosted by OBN. Join us at Convene, 133 Houndsditch, London, on April 23-24.

This gathering is an opportunity for us to engage with industry leaders and forward-thinking investors who are as passionate about peptide chemistry and drug conjugates as we are. We're looking forward to discussing our latest breakthroughs and exploring how they can drive the future of healthcare and treatment solutions.

🤝 Looking to Connect?
If you're heading to BioTrinity as well, let's make plans to meet. Sutura is all about fostering connections that lead to meaningful collaborations. Whether you're an investor looking for groundbreaking investment opportunities or a fellow innovator keen to explore potential synergies, we're here to dive deeper into discussions about the possibilities that lie ahead. Email us to set up a meeting:
LetsTalk@sutura.com

📅 Save the Date:
Event: BioTrinity 2024
Dates: April 23-24
Location: Convene, 133 Houndsditch, London
Register:
https://obn.glueup.com/event/biotrinity-2024-80960/registration.html

Let’s shape the future of biotechnology together. Reach out to us, and let’s schedule a time to connect at the conference.

Previous
Previous

A Successful BioTrinity 2024 for Sutura

Next
Next

PeptiGos, a Next Generation CPP Platform